Genecentric Therapeutics, Inc.

Durham, NC

UEI
RZKQKXFT3VQ5
CAGE
7BWF0
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
6 Davis Dr Suite 146, Durham, NC 27709, USA
Website
genecentric.com
Founded
2011
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Similar vendors

Vendor Location Primary NAICS
Genus Biosystems Inc. UEI YUS9H4YC76E7 Northbrook, IL 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Creatv Microtech Inc. UEI R9KLWUK6L2B7 Potomac, MD 541714 Research and Development in Biotechnology (except Nanobiotechnology)
WRI UEI N9LUQAMQPGZ8 Windber, PA 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Tymora Analytical Operations LLC UEI ZFFZKDYTF5Q9 West Lafayette, IN 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Ontario Institute For Cancer Research Institut Ontarien De Recherche SUR LE Cancer UEI LH6LETZC1CJ5 Toronto, ON 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

See more similar vendors on GovTribe

About the company

Written by GovTribe AI ·

Genecentric Therapeutics, Inc. is a for-profit corporation specializing in decoding tumor biology and developing RNA-based diagnostics for cancer. They provide molecular diagnostic tests for oncologists and patients using an RNA-based informatics pipeline. Through federal grants, Genecentric Therapeutics provides research services to develop gene expression-based subtyping and prognostic assays for cancers. As a subawardee, Genecentric has collaborated with The Washington University on a project sponsored by the National Institutes of Health to develop a four-class molecular subtyping diagnostic for HPV-negative head and neck cancer. Deliverables include bioinformatics analysis and development of reduced gene signatures to subtype head and neck squamous cell carcinoma tumors.

Quick answers

Is Genecentric Therapeutics, Inc. registered in SAM.gov?

Yes. Genecentric Therapeutics, Inc.'s SAM.gov registration is active through June 24, 2027.

On GovTribe

See Genecentric Therapeutics, Inc.'s full federal record

  • Similar vendors
Try for free Login